olomoucine has been researched along with Glial Cell Tumors in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cruz, M; Siden, A; Tasat, DR; Vita, MF; Yakisich, JS | 1 |
| Corcoran, GB; Gautam, SC; Groc, L; Hunter, TJ; Jiang, H; Koubi, D; Kuo, J; Kuo, K; Levine, RA; Rodriguez, AI; Seidman, MD; Zhang, L | 1 |
2 other study(ies) available for olomoucine and Glial Cell Tumors
| Article | Year |
|---|---|
Strong inhibition of replicative DNA synthesis in the developing rat cerebral cortex and glioma cells by roscovitine.
Topics: Age Factors; Animals; Animals, Newborn; Anticarcinogenic Agents; Cell Line, Tumor; Cerebral Cortex; DNA; DNA Damage; DNA Repair; Drug Screening Assays, Antitumor; Glioma; Humans; In Vitro Techniques; Kinetin; Nucleic Acid Synthesis Inhibitors; Protein Kinase Inhibitors; Purines; Rats; Rats, Sprague-Dawley; Roscovitine | 2010 |
Resveratrol-induced apoptotic death in human U251 glioma cells.
Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Caspase 3; Caspase 9; Caspase Inhibitors; Caspases; Cell Cycle; Cell Line, Tumor; Cytochromes c; Cytoplasm; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Glioma; Humans; Kinetin; L-Lactate Dehydrogenase; Phenols; Poly(ADP-ribose) Polymerases; Polyphenols; Proto-Oncogene Proteins c-bcl-2; Purines; Resveratrol; Signal Transduction; Stilbenes; Subcellular Fractions; Time Factors; Up-Regulation | 2005 |